You are using an outdated browser. Please upgrade your browser to improve your experience.

You are here

Coronary Artery Disease

The PMC reviewed relevant performance measures and makes the following recommendations.

Printable version of the recommendations.

ACP supports this measure.

ID# NQF 0066

More Information

Coronary Artery Disease: ACE Inhibitor or ARB Therapy-Diabetes or Left Ventricular Systolic Dysfunction (LVEF <40%)

Percent of patients aged 18 years and older undergoing isolated CABG who die, including both: 1) all deaths occurring during the hospitalization in which the CABG was performed, even if after 30 days, and 2) those deaths occurring after discharge from the hospital, but within 30 days of the procedure.
Date Reviewed: November 7, 2015

ACP supports this measure.

ID# NQF 0067
ID# QPP 006

More Information

Chronic Stable Coronary Artery Disease: Antiplatelet Therapy

 Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease (CAD) seen within a 12 month period who were prescribed aspirin or clopidogrel.
Date Reviewed: November 19, 2017

ACP does not support this measure.

ID# NQF 0070
ID# QPP 007

More Information

Coronary Artery Disease: Beta Blocker Therapy - Prior Myocardial Infarction or Left Ventricular Systolic Dysfunction (LVEF <40%)

Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period who also have a prior myocardial infarction or a current or prior LVEF <40% who were prescribed beta-blocker therapy.
Date Reviewed: November 19, 2017